Agilent Technologies, Inc. (NYSE:A) Shares Purchased by Corient Private Wealth LLC

Corient Private Wealth LLC grew its stake in Agilent Technologies, Inc. (NYSE:A) by 0.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 258,612 shares of the medical research company’s stock after purchasing an additional 1,665 shares during the quarter. Corient Private Wealth LLC’s holdings in Agilent Technologies were worth $34,742,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Vestal Point Capital LP bought a new position in Agilent Technologies in the third quarter worth about $14,848,000. Empowered Funds LLC grew its position in Agilent Technologies by 29.8% in the 3rd quarter. Empowered Funds LLC now owns 30,978 shares of the medical research company’s stock valued at $4,592,000 after buying an additional 7,111 shares in the last quarter. Sienna Gestion increased its stake in shares of Agilent Technologies by 29.8% during the fourth quarter. Sienna Gestion now owns 78,445 shares of the medical research company’s stock valued at $10,537,000 after acquiring an additional 17,991 shares during the period. S.E.E.D. Planning Group LLC increased its position in shares of Agilent Technologies by 12.7% during the 4th quarter. S.E.E.D. Planning Group LLC now owns 42,587 shares of the medical research company’s stock valued at $5,721,000 after purchasing an additional 4,805 shares during the period. Finally, Sequoia Financial Advisors LLC raised its position in Agilent Technologies by 8.5% in the fourth quarter. Sequoia Financial Advisors LLC now owns 33,898 shares of the medical research company’s stock worth $4,554,000 after acquiring an additional 2,664 shares in the last quarter.

Agilent Technologies Stock Up 1.2 %

Shares of A stock opened at $122.63 on Tuesday. The stock has a fifty day moving average price of $137.99 and a 200 day moving average price of $137.82. The stock has a market cap of $34.96 billion, a P/E ratio of 28.19, a price-to-earnings-growth ratio of 3.40 and a beta of 1.11. Agilent Technologies, Inc. has a one year low of $117.17 and a one year high of $155.35. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.20 and a quick ratio of 1.66.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating the consensus estimate of $1.27 by $0.04. The business had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. Analysts predict that Agilent Technologies, Inc. will post 5.57 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be given a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.99 annualized dividend and a yield of 0.81%. Agilent Technologies’s payout ratio is 22.76%.

Insider Buying and Selling

In related news, CEO Padraig Mcdonnell sold 1,911 shares of the business’s stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the sale, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at $5,947,800. The trade was a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on A. Citigroup raised their price objective on Agilent Technologies to $165.00 and gave the stock a “buy” rating in a research note on Thursday, December 19th. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Robert W. Baird reduced their target price on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a research note on Thursday, February 27th. Sanford C. Bernstein decreased their price target on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research note on Tuesday, November 26th. Finally, Barclays upgraded shares of Agilent Technologies from an “underweight” rating to an “equal weight” rating and raised their target price for the company from $135.00 to $145.00 in a research note on Monday, February 10th. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $146.15.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.